GLP-1 & Obesity
GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.
92 stocks
Value
Increase
Decrease
Funds Holding
3,771
Funds Holding Change
0
Funds Holding Growth
0%
Value
$687B
Holding in Top 10
319
Top 10 Change
-21
Top 10 Growth
-6%
Value Growth
+3%
New
201
Increased
1,796
Reduced
1,523
Closed
154
Capital Inflow
$25.9B
Capital Outflow
$21.6B
Net Capital Flow
+$4.24B
Capital Flow Change
+$9.81B
Calls
$6.83B
Puts
$7.45B
Net Calls
-$625M
Put/Call Ratio
1.09